1. Outcomes of Hematopoietic Cell Transplantation in Adult Patients with Acquired Aplastic Anemia Using Intermediate-Dose Alemtuzumab-Based Conditioning 
Nada Hamad, Ryan Del Bel, Hans A. Messner, Dennis Kim, John Kuruvilla, Jeffrey H. Lipton, Jieun Uhm, Matthew Seftel, Naheed Alam, Wei Xu, Vikas Gupta 
Biology of Blood and Marrow Transplantation 
Volume 20, Issue 11, Pages (November 2014)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Transplantation outcomes in aplastic anemia HCT using alemtuzumab-based conditioning. (A) Shows cumulative incidence of acute GVHD (all grades I to II). (B) Shows cumulative incidence of chronic GVHD (all mild to moderate). (C) Shows 3-year overall survival Kaplan-Meier plot.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
Viral complications and PTLD in aplastic anemia HCT using alemtuzumab-based conditioning. (A) Shows cumulative incidence of viral infections. (B) Shows cumulative incidence of PTLD.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions